LabMedica

Download Mobile App
Recent News Expo
Medica 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fapon Showcases AI-Engineered Enzymes and RNA Workflows at AMP 2026

By LabMedica International staff writers
Posted on 16 Nov 2026

Fapon showcased its AI-engineered enzymes, reverse transcription technologies, and nucleic acid library preparation solutions at the Association for Molecular Pathology (AMP) 2026 Annual Meeting & Expo, held November 10–14 in Seattle, Washington. The company highlighted technologies for quantitative PCR (qPCR), reverse transcription PCR (RT-qPCR), and next-generation sequencing (NGS), focusing on enzyme performance and integrated molecular testing workflows.

Among the featured products was ProPrime II Taq DNA Polymerase, a second-generation antibody hot-start enzyme designed for rapid and multiplex PCR applications. The polymerase achieves complete antibody release within 10 seconds of heat activation and supports quadruplex qPCR in under 20 minutes. Evaluations demonstrated amplification in samples containing 5% whole blood and nine common PCR inhibitors, including hemoglobin and EDTA.


Image Credit: iStock
Image Credit: iStock

Fapon also presented MeloScript III WS Reverse Transcriptase, a third-generation hot-start enzyme developed for one-step RT-qPCR applications. The enzyme demonstrated approximately 64% blocking efficiency after one hour at 37°C and maintained reverse transcription performance following 10 minutes at temperatures between 52°C and 64°C. Its glycerol-free, lyophilization-ready formulation supports applications in near-patient molecular testing.

The company's reverse transcription portfolio also includes PreciAmp HS RT for reverse transcription loop-mediated isothermal amplification (RT-LAMP) and VeloScript I for short- and long-read NGS workflows. VeloScript I supports RNA inputs ranging from 10 pg to 10 µg and synthesizes full-length complementary DNA (cDNA) up to 15 kb at 55°C. The enzyme is designed for applications involving single-cell analysis and limited RNA samples.

For downstream sequencing, Fapon highlighted its RNA library preparation solutions, including the NK081 Poly(A) mRNA Magnetic Isolation Module. The module removes at least 95% of ribosomal RNA in under 40 minutes, while its stranded and non-stranded RNA library preparation kits support inputs from 1 ng to 1 µg. The kits are compatible with sequencing platforms from Illumina, MGI, GeneMind, and Salus.

The company's DNA library preparation portfolio includes the NextGen Universal FS DNA Library Prep Kit, which uses enzymatic fragmentation and completes library preparation in under one hour. Together, these RNA and DNA solutions are designed to support molecular pathology workflows ranging from nucleic acid processing to sequencing library construction.

Fapon also hosted a technical workshop titled "Unlocking the Full Potential of Enzymes in Molecular Diagnostics." The session examined how AI-assisted enzyme engineering can improve performance across qPCR, RT-qPCR, NGS, and isothermal amplification. Presentations also addressed full-length transcriptomics and its application in resolving complex fusion genes and transcript isoforms.

Fapon's enzyme development approach combines AI-driven molecular design with high-throughput laboratory characterization to evaluate thermostability, sensitivity, specificity, amplification speed, and inhibitor resistance. The company also provides custom enzyme development, reagent formulations, and manufacturing services through bulk supply and OEM/ODM arrangements for in vitro diagnostic manufacturers.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Platelet Function Analyzer
PL-12

Latest Molecular Diagnostics News

AMP 2026 Underscores Molecular Testing’s Role in Precision Medicine for Women’s Health
16 Nov 2026  |   Molecular Diagnostics

Target-Amplification-Free CRISPR Platform Demonstrates Molecular Detection in Under 10 Minutes
16 Nov 2026  |   Molecular Diagnostics

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026
16 Nov 2026  |   Molecular Diagnostics